Polymorphous Light Eruption

被引:14
作者
Guarrera, Marcella [1 ]
机构
[1] Univ Genoa, Genoa, Italy
来源
ULTRAVIOLET LIGHT IN HUMAN HEALTH, DISEASES AND ENVIRONMENT | 2017年 / 996卷
关键词
Polymorphous light eruption; Idiopathic photodermatosis; Immunomediated photodermatosis; UV light; Phototests; Minimal erythema dose; Photoprovocation tests; JUVENILE SPRING ERUPTION; VITAMIN-D STATUS; FOLLOW-UP; AFRICAN-AMERICANS; ANTINUCLEAR ANTIBODIES; POLYPODIUM-LEUCOTOMOS; ANTIOXIDANT CAPACITY; LUPUS-ERYTHEMATOSUS; IMMUNE SUPPRESSION; ULTRAVIOLET UV;
D O I
10.1007/978-3-319-56017-5_6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Polymorphous light eruption (PLE) is the commonest immuno-mediated photodermatosis. It occurs after solar or artificial UV-light exposure and affects only the sun-exposed areas with preference of the V-area of the chest, of arms and forearms, legs, upper part of the back, and rarely the face. The lesions are itching or burning, and vary morphologically from erythema to papules, vesico-papules and occasionally blisters, plaques, sometimes erythema multiforme-like, insect bite-like wheals and purpura. The clinical manifestations befall within a few hours to days from light exposure, last a few days, and subside in about a week without sequelae. Its diagnosis is based on history, morphology and phototests. PLE is considered as a delayed hypersensitivity response to newly UV induced, but still unidentified, antigen(s). Usually, MED is normal, but the provocative phototests with UVA or UVB reproduce the spontaneous lesions in about 50% of the patients. Broad spectrum sunscreens and antioxidants, photohardening with PUVA or narrow band UVB may be beneficial to prevent the disease. Therapy is based mainly on topical or systemic corticosteroids.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 104 条
[1]   Persistent polymorphous light eruption after ultraviolet A1 phototherapy [J].
AlJasser, Mohammed I. ;
Lui, Harvey ;
Ball, Nigel J. ;
Kalia, Sunil .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2013, 29 (01) :52-54
[2]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[3]   Why is polymorphous light eruption so common in young women? [J].
Aubin, F .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 296 (05) :240-241
[4]   Pinpoint papular variant of polymorphous light eruption: Clinical and pathological correlation [J].
Bansal, I ;
Kerr, H ;
Janiga, JJ ;
Qureshi, HS ;
Chaffins, M ;
Lim, HW ;
Ormsby, A .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (04) :406-410
[5]  
Bateman D., 1817, DELINEATIONS CUTANEO
[6]   A COMPARISON OF NARROW-BAND PHOTOTHERAPY (TL-01) AND PHOTOCHEMOTHERAPY (PUVA) IN THE MANAGEMENT OF POLYMORPHIC LIGHT ERUPTION [J].
BILSLAND, D ;
GEORGE, SA ;
GIBBS, NK ;
AITCHISON, T ;
JOHNSON, BE ;
FERGUSON, J .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (06) :708-712
[7]   Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption [J].
Bissonnette, Robert ;
Nigen, Simon ;
Bolduc, Chantal .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2012, 28 (05) :240-243
[8]  
BOONSTRA H, 1989, PHOTODERMATOLOGY, V6, P56
[9]   Polymorphous light eruption: A clinical, photobiologic, and follow-up study of 110 patients [J].
Boonstra, HE ;
van Weelden, H ;
Toonstra, J ;
van Vloten, WA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (02) :199-207
[10]   Ectoin: An effective natural substance to prevent UVA-induced premature photoaging [J].
Buenger, J ;
Driller, H .
SKIN PHARMACOLOGY AND PHYSIOLOGY, 2004, 17 (05) :232-237